MS

Biogen's Tecfidera faces new challenge as scientists call for brain infection monitoring
Fierce Pharma
Fri, 08/7/15 - 05:41 pm
Biogen
Tecfidera
MS
multiple sclerosis
FDA updates label for Novartis' MS pill Gilenya after reports of brain infection
Fierce Pharma
Wed, 08/5/15 - 02:46 pm
FDA
Novartis
Gilenya
MS
multiple sclerosis
Will Biogen Win From Novartis MS Drug Safety Label Change?
Yahoo/24 7 Wall St
Tue, 08/4/15 - 06:54 pm
Biogen
Novartis
MS
multiple sclerosis
Gilenya
Pfizer and Synthon Enter Into U.S. Commercialization Agreement for Potential Generic Treatment of Multiple Sclerosis
Yahoo
Mon, 08/3/15 - 09:09 am
Pfizer
Synthon Pharmaceuticals
MS
multiple sclerosis
Copaxone
generics
Sanofi calls out Genzyme, multiple sclerosis drug, as main drivers of growth again
Bizjournals.com
Thu, 07/30/15 - 10:33 am
Sanofi
Genzyme
MS
multiple sclerosis
Aubagio
earnings
Teva's MS drug Copaxone has strong second-quarter sales
Yahoo/Reuters
Thu, 07/30/15 - 10:31 am
Teva Pharmaceutical
Copaxone
MS
multiple sclerosis
earnings
Novartis off to scorching start with Copaxone generic Glatopa
Fierce Pharma Marketing
Mon, 07/13/15 - 11:11 am
Novartis
Copaxone
generics
Glatopa
MS
multiple scleroiss
Momenta
Sandoz
Roche's MS hopeful will amp up payer pricing pressure, analyst says
Fierce Pharma Marketing
Wed, 07/8/15 - 11:41 am
Roche
MS
multiple sclerosis
ocrelizumab
Roche heralds PhIII successes for MS, but some tough rivals lie in wait
Fierce Biotech
Tue, 06/30/15 - 10:43 am
Roche
multiple sclerosis
ocrelizumab
MS
It's Teva vs. Momenta/Sandoz for Copaxone patients, with Mylan's version MIA
Fierce Pharma Marketing
Mon, 06/22/15 - 10:52 am
Teva Pharmaceutical
Momenta
Sandoz
generics
Novartis
Copaxone
MS
multiple sclerosis
Despite insider sale, Receptos stock surges on takeover rumors
BioPharma Dive
Thu, 06/18/15 - 11:14 am
Receptos
M&A
AstraZeneca
Teva Pharmaceutical
Gilead Sciences
MS
multiple sclerosis
Genzyme, Ablynx form multiple sclerosis pact
Pharma Times
Mon, 05/18/15 - 11:29 am
Genzyme
Ablynx
MS
multiple sclerosis
R&D
Is This Biogen's Next Billion-Dollar Blockbuster?
Investopedia
Tue, 05/12/15 - 08:15 am
Biogen Idec
Zinbryta
MS
multiple sclerosis
Multiple Sclerosis Drug Prices Rose at an ‘Alarming’ Rate: Study
WSJ Pharmalot
Sun, 04/26/15 - 09:19 am
drug pricing
MS
multiple sclerosis
FDA Approves Generic Copaxone, but When Will it Become Available?
WSJ Pharmalot
Fri, 04/17/15 - 08:39 am
FDA
generics
Copaxone
MS
multiple sclerosis
Teva Pharmaceutical
FDA approves first generic version of Teva MS drug Copaxone
Yahoo/Reuters
Thu, 04/16/15 - 09:46 pm
FDA
generics
Teva Pharmaceutical
Copaxone
MS
multiple sclerosis
Actelion launches Phase III MS test for ponesimod
Fierce Biotech
Thu, 04/16/15 - 12:31 pm
Actelion
MS
multiple sclerosis
ponesimod
Should Biogen Be Afraid of This Upstart?
Investopedia
Mon, 04/13/15 - 10:02 pm
Biogen
Receptos
MS
multiple sclerosis
ozanimod
Tecfidera
Merck KGaA pitches in an extra $3M to support Opexa's PhIIb for MS
Fierce Biotech
Mon, 03/9/15 - 12:01 pm
Merck KGaA
Opexa
Serono
MS
multiple sclerosis
Merck's Rebif held its own in last year's MS market shakeup. What about 2015?
Fierce Pharma
Tue, 03/3/15 - 01:27 pm
Rebif
MS
multiple sclerosis
Merck KGaA

Pages